Overall market sentiment has been high on Meridian Bioscience, Inc. (VIVO) stock lately. VIVO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Meridian Bioscience, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VIVO!
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With VIVO Stock Today?
Meridian Bioscience, Inc. (VIVO) stock is trading at $18.85 as of 1:20 PM on Thursday, Jul 22, an increase of $0.51, or 2.78% from the previous closing price of $18.34. The stock has traded between $18.34 and $18.94 so far today. Volume today is less active than usual. So far 273,418 shares have traded compared to average volume of 505,072 shares.
To screen for more stocks like Meridian Bioscience, Inc. click here.
More About Meridian Bioscience, Inc.
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Click Here to get the full Stock Report for Meridian Bioscience, Inc. stock.